Sihuan Pharm
About Sihuan
News
Investor Relations
Contact Us
简/繁/EN
Product Portfolio/Innovative Drugs/Product Detail
Sihuan Pharm
Phone+86 (010) 57693700
Postcode100025
Corporate Address22F, Building 4, Zhubang 2000, Balizhuang Xili, Chaoyang District, Beijing, China

About Sihuan

  • Corporate Overview
  • Brand & Culture
  • History
  • Members
  • Leadership Team
  • Honors
  • ESG

Products

  • Medical Aesthetics
  • Innovative Drugs
  • Mature Medicines
  • Medication Safety

R&D Innovation

  • R&D System
  • Open Collaboration
  • Quality & Safety
  • Commercialization

Investor Relations

  • Disclosure
  • Governance
  • IR Calendar
  • News Release
  • Stock Information
  • IR Contact

Statements & Notices

  • Disclaimer
  • Pharma Reps Registry
WeChat Official Account

WeChat Official Account

Sihuan IR
WeChat Account

Sihuan IR WeChat Account

© Sihuan Pharmaceutical Holdings Group Ltd.Hong Kong Stock Exchange Stock Code: 00460.HKBeijing 11011202000890 · Beijing ICP 15000973药监批号 (京)-非经营性-2019-0013

恩格列净

惠优信

恩格列净

恩格列净

Product Information

Brand
惠优信
Generic Name
恩格列净
Dosage Form
片剂
Approval No.
国药准字 H20249837
Validity Period
24个月
Manufacturer
南京海纳制药有限公司
MAH
惠升生物制药股份有限公司
Drug Category
处方药

Overview

经典 SGLT-2 抑制剂,降糖同时可护心肾,用于成人 2 型糖尿病血糖控制,降低心血管风险

Indications

用于治疗2型糖尿病

Usage & Dosage

口服,起始 10mg 一日 1 次,晨起服用;降糖不足可增至 25mg 一日 1 次,不受进食影响

Contraindications

1. 对恩格列净或辅料过敏者禁用。 2.1 型糖尿病、酮症酸中毒、重度肾衰、终末期肾病透析患者禁用。 (See leaflet for details)

Precautions

1. 渗透性利尿易致脱水、低血压,老年、联用利尿剂人群监测血压。 2. 警惕生殖器坏死性筋膜炎、下肢感染截肢风险。 3. 肾功下降需评估减量或停药。 4. 手术、禁食前建议暂停用药防酮症。 (See leaflet for details)

Storage

密封保存